NCT00240058View on ClinicalTrials.gov

Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Blood Pressure
Interventions
DRUG

Regional phenylephrine arterial infusion, Nitric Oxide Clamp

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of Michigan

OTHER

lead

Crystal A. Gadegbeku

OTHER

NCT00240058 - Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity | Biotech Hunter | Biotech Hunter